The veterinary biologics market size is witnessing significant expansion as the global animal healthcare ecosystem transitions toward advanced therapeutic solutions. Biologics, particularly monoclonal antibodies (mAbs), are emerging as transformative tools in treating chronic and complex diseases in companion animals. These therapies offer targeted mechanisms of action, reduced side effects,...
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek